NUZYRA™ (omadacycline)100 mg for injection/150 mg tablets
Minimal inhibitory concentration of omadacycline and doxycycline against bacterial isolates with known tetracycline resistance determinants
Omadacycline gut microbiome exposure does not induce Clostridium difficile proliferation or toxin production in a model that simulates the proximal, medial and distal human colon
See the latest publications and presentations from Paratek Pharmaceuticals in the links below:
Send us an inquiry by submitting a form directly on the site or give us a call.
You are now leaving the Paratek Corporate Website